Triple-Negative Breast Cancer Latest Advances

Find the Latest Research About Triple-Negative Breast Cancer

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4210 publications

Liquid Biopsy Biomarkers as Predictors of TNBC Recurrence: A Systematic Review.

Liquid Biopsy Biomarkers as Predictors of TNBC Recurrence: A Systematic Review.

Journal: Cancer investigation
Published: June 09, 2026

The tumor microenvironment in triple negative breast cancer and a strategy to improve responses to immunotherapy using cryoablation and immunostimulants.

The tumor microenvironment in triple negative breast cancer and a strategy to improve responses to immunotherapy using cryoablation and immunostimulants.

Journal: Cancer biology & therapy
Published: June 05, 2026

Tumor-Associated Platelets Suppress T-Cell Function and Promote Immune Evasion in TNBC via the P-selectin/ P-selectin glycoprotein ligand-1 Pathway.

Tumor-Associated Platelets Suppress T-Cell Function and Promote Immune Evasion in TNBC via the P-selectin/ P-selectin glycoprotein ligand-1 Pathway.

Journal: Cancer research communications
Published: May 19, 2026

Erratum: [Corrigendum] Proliferation, migration and invasion of triple negative breast cancer cells are suppressed by berbamine via the PI3K/Akt/MDM2/p53 and PI3K/Akt/mTOR signaling pathways.

Erratum: [Corrigendum] Proliferation, migration and invasion of triple negative breast cancer cells are suppressed by berbamine via the PI3K/Akt/MDM2/p53 and PI3K/Akt/mTOR signaling pathways.

Journal: Oncology letters
Published: May 18, 2026

The functional dichotomy of exosomal microRNAs in TNBC: implications for chemoresistance and integrated theranostics.

The functional dichotomy of exosomal microRNAs in TNBC: implications for chemoresistance and integrated theranostics.

Journal: Molecular biology reports
Published: May 15, 2026

Fabrication of β-Glucan Nanocarriers for Enhanced Encapsulation and Delivery of Doxorubicin for Triple Negative Breast Cancer Treatment.

Fabrication of β-Glucan Nanocarriers for Enhanced Encapsulation and Delivery of Doxorubicin for Triple Negative Breast Cancer Treatment.

Journal: Bioscience, biotechnology, and biochemistry
Published: May 04, 2026

MOF-based arginine nanocarriers for coordinated immunometabolic and antitumor modulation in triple negative breast cancer.

MOF-based arginine nanocarriers for coordinated immunometabolic and antitumor modulation in triple negative breast cancer.

Journal: Biomaterials science
Published: April 24, 2026

Lines Left Uncrossed: The Cost of Attrition in Metastatic Triple Negative Breast Cancer.

Lines Left Uncrossed: The Cost of Attrition in Metastatic Triple Negative Breast Cancer.

Journal: Cureus
Published: April 18, 2026

Integrative Transcriptomic and Machine Learning Analysis of ecDNA-Associated Features for Studying Chemotherapy Resistance in TNBC.

Integrative Transcriptomic and Machine Learning Analysis of ecDNA-Associated Features for Studying Chemotherapy Resistance in TNBC.

Journal: bioRxiv : the preprint server for biology
Published: April 17, 2026

CRE26-067: Treatment Response to Lenvatinib in Metastatic Adenoid Cystic Triple Negative Breast Cancer: A Case Report.

CRE26-067: Treatment Response to Lenvatinib in Metastatic Adenoid Cystic Triple Negative Breast Cancer: A Case Report.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 16, 2026

OS benefit with first-line datopotamab deruxtecan in advanced-stage TNBC.

OS benefit with first-line datopotamab deruxtecan in advanced-stage TNBC.

Journal: Nature reviews. Clinical oncology
Published: April 15, 2026

Targeting neuropilin-1 attenuates 4-hydroxytamoxifen-induced stemness and sensitizes ERα-re-expressing TNBC to tamoxifen.

Targeting neuropilin-1 attenuates 4-hydroxytamoxifen-induced stemness and sensitizes ERα-re-expressing TNBC to tamoxifen.

Journal: Biochemical pharmacology
Published: April 14, 2026
Showing 1-12 of 4,210

Last Updated: 06/30/2026